Supernus Pharmaceuticals, Inc. (SUPN)
56.44
+3.14
(+5.90%)
USD |
NASDAQ |
Feb 25, 14:07
Supernus Pharmaceuticals Price : 56.44 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 190.23 |
| Catalyst Pharmaceuticals, Inc. | 24.74 |
| Oncotelic Therapeutics, Inc. | 0.0476 |
| Vertex Pharmaceuticals, Inc. | 482.63 |
| Krystal Biotech, Inc. | 272.70 |
Price Related Metrics
| PS Ratio | 4.669 |
| Price to Book Value | 3.083 |
| Price to Free Cash Flow | 44.98 |
| Earnings Yield | -0.60% |
| Market Cap | 3.237B |